Ana M. Tari

3.2k total citations
65 papers, 2.6k citations indexed

About

Ana M. Tari is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ana M. Tari has authored 65 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 23 papers in Oncology and 12 papers in Genetics. Recurrent topics in Ana M. Tari's work include Retinoids in leukemia and cellular processes (14 papers), HER2/EGFR in Cancer Research (12 papers) and Estrogen and related hormone effects (12 papers). Ana M. Tari is often cited by papers focused on Retinoids in leukemia and cellular processes (14 papers), HER2/EGFR in Cancer Research (12 papers) and Estrogen and related hormone effects (12 papers). Ana M. Tari collaborates with scholars based in United States, Mexico and Canada. Ana M. Tari's co-authors include Gabriel Lopez‐Berestein, Ann‐Marie Simeone, Musaffe Tuna, René Nieves-Alicea, Bülent Özpolat, Mien‐Chie Hung, Seiji Kondo, Pablo Zapata‐Benavides, Yasuko Kondo and Michael Andreeff and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Ana M. Tari

65 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana M. Tari United States 31 1.7k 708 367 256 238 65 2.6k
Christine Fritsch Switzerland 21 1.8k 1.0× 610 0.9× 258 0.7× 217 0.8× 122 0.5× 39 2.6k
François X. Claret United States 30 1.9k 1.1× 1.0k 1.4× 599 1.6× 251 1.0× 219 0.9× 52 2.8k
Dona Alberti United States 30 1.4k 0.8× 1.0k 1.5× 387 1.1× 226 0.9× 136 0.6× 90 2.8k
Richard Kendall United States 24 1.8k 1.0× 837 1.2× 476 1.3× 153 0.6× 240 1.0× 43 3.0k
Pavel G. Komarov United States 17 1.5k 0.9× 1.1k 1.6× 375 1.0× 104 0.4× 120 0.5× 27 2.6k
Cinzia Lanzi Italy 33 1.5k 0.9× 895 1.3× 317 0.9× 126 0.5× 124 0.5× 73 2.4k
Anette Sommer Germany 25 1.2k 0.7× 699 1.0× 323 0.9× 206 0.8× 162 0.7× 63 2.0k
V. Ashutosh Rao United States 27 2.4k 1.4× 1.3k 1.8× 523 1.4× 134 0.5× 164 0.7× 70 3.4k
Jiazhi Sun United States 23 2.2k 1.3× 1.2k 1.8× 355 1.0× 260 1.0× 119 0.5× 42 3.3k
Chandra Bartholomeusz United States 24 1.2k 0.7× 867 1.2× 416 1.1× 142 0.6× 140 0.6× 44 2.0k

Countries citing papers authored by Ana M. Tari

Since Specialization
Citations

This map shows the geographic impact of Ana M. Tari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana M. Tari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana M. Tari more than expected).

Fields of papers citing papers by Ana M. Tari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana M. Tari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana M. Tari. The network helps show where Ana M. Tari may publish in the future.

Co-authorship network of co-authors of Ana M. Tari

This figure shows the co-authorship network connecting the top 25 collaborators of Ana M. Tari. A scholar is included among the top collaborators of Ana M. Tari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana M. Tari. Ana M. Tari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Dongwei, Ana M. Tari, Uǧur Akar, et al.. (2010). Silencing Kinase-Interacting Stathmin Gene Enhances Erlotinib Sensitivity by Inhibiting Ser10 p27 Phosphorylation in Epidermal Growth Factor Receptor–Expressing Breast Cancer. Molecular Cancer Therapeutics. 9(11). 3090–3099. 17 indexed citations
2.
Costelloe, Colleen M., Eric Rohren, John E. Madewell, et al.. (2009). Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. The Lancet Oncology. 10(6). 606–614. 140 indexed citations
3.
Tuna, Musaffe, Arturo Chávez‐Reyes, & Ana M. Tari. (2005). HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene. 24(9). 1648–1652. 65 indexed citations
4.
Simeone, Ann‐Marie, Stefano Colella, Ralf Krahe, et al.. (2005). N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells. Carcinogenesis. 27(3). 568–577. 32 indexed citations
5.
Mendoza-Gamboa, Edgar, Doris R. Siwak, & Ana M. Tari. (2004). The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells. Oncology Reports. 12(4). 903–8. 7 indexed citations
6.
Simeone, Ann‐Marie, Yujiang Li, Lyle D. Broemeling, et al.. (2004). Cyclooxygenase-2 Is Essential for HER2/ neu to Suppress N - (4-Hydroxyphenyl)retinamide Apoptotic Effects in Breast Cancer Cells. Cancer Research. 64(4). 1224–1228. 39 indexed citations
7.
Tari, Ana M., et al.. (2004). How retinoids regulate breast cancer cell proliferation and apoptosis. Cellular and Molecular Life Sciences. 61(12). 1475–84. 101 indexed citations
8.
Le, Xiao-Feng, François-Xavier Claret, Ling Tian, et al.. (2003). The Role of Cyclin-dependent Kinase Inhibitor p27Kip1 in Anti-HER2 Antibody-induced G1 Cell Cycle Arrest and Tumor Growth Inhibition. Journal of Biological Chemistry. 278(26). 23441–23450. 123 indexed citations
9.
Tari, Ana M., et al.. (2003). Cellular Pharmacology of P-ethoxy Antisense Oligonucleotides Targeted to Bcl-2 in a Follicular Lymphoma Cell Line. Leukemia & lymphoma. 44(11). 1979–1985. 10 indexed citations
10.
Tari, Ana M., Soo-Jeong Lim, Mien‐Chie Hung, Francisco J. Esteva, & Gabriel Lopez‐Berestein. (2002). Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells. Oncogene. 21(34). 5224–5232. 63 indexed citations
11.
Zapata‐Benavides, Pablo, et al.. (2002). Bcl-2[ndash ]related antisense therapy. Seminars in Oncology. 29(3 Suppl 11). 71–76. 18 indexed citations
12.
Siwak, Doris R., Ana M. Tari, & Gabriel Lopez‐Berestein. (2002). The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002.. PubMed. 8(4). 955–6. 37 indexed citations
13.
14.
Lim, Soo‐Jeong, Ann‐Marie Simeone, Chong‐Kook Kim, & Ana M. Tari. (2002). Cyclosporin A enhances the apoptotic effects of N‐(4‐hydroxyphenyl)retinamide in breast cancer cells. International Journal of Cancer. 101(3). 243–247. 14 indexed citations
15.
Tari, Ana M.. (2001). GRB2: A pivotal protein in signal transduction. Seminars in Oncology. 28(5 Suppl 16). 142–147. 93 indexed citations
16.
Lim, Soo-Jeong, Gabriel Lopez‐Berestein, Mien‐Chie Hung, Ruth Lupu, & Ana M. Tari. (2000). Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells. Oncogene. 19(54). 6271–6276. 35 indexed citations
17.
Tari, Ana M., Clifton Stephens, Michael G. Rosenblum, & Gabriel Lopez‐Berestein. (1998). Pharmacokinetics, Tissue Distribution, and Safety of P-Ethoxy Oligonucleotides Incorporated in Liposomes. Journal of Liposome Research. 8(2). 251–264. 12 indexed citations
18.
Tormo, Mar, Ana M. Tari, Timothy J. McDonnell, et al.. (1998). Apoptotic Induction in Transformed Follicular Lymphoma Cells by Bcl-2 Downregulation. Leukemia & lymphoma. 30(3-4). 367–380. 33 indexed citations
19.
Tari, Ana M. & G. Lopez‐Berestein. (1993). Antisense oligonucleotides and carriers for gene therapy. 45(2). 164–170. 4 indexed citations
20.
Tari, Ana M. & Leaf Huang. (1989). Structure and function relationship of phosphatidylglycerol in the stabilization of phosphatidylethanolamine bilayer. Biochemistry. 28(19). 7708–7712. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Fritsch Breakdown of academic impact, for papers by François X. Claret Breakdown of academic impact, for papers by Dona Alberti Breakdown of academic impact, for papers by Richard Kendall Breakdown of academic impact, for papers by Pavel G. Komarov Breakdown of academic impact, for papers by Cinzia Lanzi Breakdown of academic impact, for papers by Anette Sommer Breakdown of academic impact, for papers by V. Ashutosh Rao Breakdown of academic impact, for papers by Jiazhi Sun Breakdown of academic impact, for papers by Chandra Bartholomeusz
Rankless by CCL
2026